South-East Asia (WHO region) vs Tanzania: Treatment success rate: XDR-TB cases
South-East Asia (WHO region)
73
in 2022
Tanzania
100
in 2022
South-East Asia (WHO region) rank
2nd
Tanzania rank
1st
Treatment success rate: XDR-TB cases over time
- South-East Asia (WHO region)
- Tanzania
How they compare
Tanzania currently reports 100 against 73 in South-East Asia (WHO region), a difference of 27.
That makes Tanzania's figure about 1.4 times South-East Asia (WHO region)'s.
The two have swapped places 3 times across 6 shared years of data; in 2014 it was South-East Asia (WHO region) ahead.
South-East Asia (WHO region) ranks 2nd and Tanzania ranks 1st of 11 groups.
South-East Asia (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South-East Asia (WHO region) | Tanzania | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 37.75 | 25 | 12.75 | South-East Asia (WHO region) |
| 2020s | 71.5 | 62.5 | 9 | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate: xdr-tb cases, South-East Asia (WHO region) or Tanzania?
- Tanzania, at 100 against 73 in South-East Asia (WHO region) as of 2022.
- What is the difference in treatment success rate: xdr-tb cases between South-East Asia (WHO region) and Tanzania?
- 27, with Tanzania ahead.
- How many years of comparable data are there for South-East Asia (WHO region) and Tanzania?
- 6 years are reported by both, from 2014 to 2022.
- How do South-East Asia (WHO region) and Tanzania rank globally for treatment success rate: xdr-tb cases?
- South-East Asia (WHO region) ranks 2nd and Tanzania ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate: XDR-TB cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.